尿液微生物群与前列腺疾病:是否是解决问题的关键?一项系统综述
该系统综述检索PubMed/Medline至2022年6月,纳入16项研究共1486例患者,分析尿液微生物群在前列腺增生、前列腺癌和慢性前列腺炎中的作用。结果显示三种疾病均存在尿液微生物组成改变,但已发表研究间异质性较大,需进一步研究确认。
要点
- 良性前列腺增生患者尿液微生物组成不同,某些模式与更严重的下尿路症状相关。
- 前列腺癌中某些细菌门/属/纲/种更丰富,另一些可预测更高分级疾病。
- 慢性前列腺炎患者微生物组成不同且多样性更高,症状严重程度主要受微生物组成影响,偏向需氧微生物。
核心结论
- 尿液微生物群与前列腺疾病相关,尤其是良性前列腺增生、前列腺癌和慢性前列腺炎。
研究设计与样本
- 系统综述,检索PubMed/Medline从建库至2022年6月,研究尿液微生物群改变与前列腺疾病的关系,按良性前列腺增生、前列腺癌和慢性前列腺炎分组。
- 研究筛选遵循PRISMA声明,纳入16项研究(良性前列腺增生4项、前列腺癌9项、慢性前列腺炎3项),共1486例患者。
- 使用非随机研究的CASP清单评估纳入研究质量。
主要发现
- 良性前列腺增生患者尿液微生物组成不同,某些模式与更高的下尿路症状严重程度相关。
- 前列腺癌中某些细菌门/属/纲/种更丰富,另一些可预测更高分级疾病。
- 慢性前列腺炎患者微生物组成不同且多样性更高,症状严重程度主要受微生物组成影响,偏向需氧微生物。
局限性
- 已发表研究间存在相对异质性,这一关联提示需要更好的界定。
- 需要进一步研究来确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinary microbiota is implicated in many diseases of the urinary tract. The aim of this study was to perform a systematic review of the role of urinary microbiota in prostatic diseases. METHODS: A PubMed/Medline search was undergone from inception through June 2022 for studies investigating urinary microbiota alterations in prostatic diseases, subdivided into benign prostatic hyperplasia (BPH), prostate cancer (PCa), and chronic prostatitis (CP). Study selection followed the PRISMA statement. Phylum, family, genus and species of each bacterium in cancer patients and controls were recorded. Quality of included studies was evaluated using the Critical Appraisal Skills Program (CASP) checklist for non-randomized studies. RESULTS: A total of 16 studies (4 studies on BPH, 9 studies on PCa and 3 studies on CP) comprising 1486 patients were included in our final analysis. Patients with BPH had a different urinary microbial composition, with a certain pattern proven to be associated with a higher lower urinary tract symptoms severity. Regarding PCa, some bacterial phyla/genera/classes/species were more abundant in PCa and others predicted a higher grade disease. In patients with CP, a different microbiota composition and a higher diversity were found, with the symptom severity being influenced mainly by microbiota composition, favoring aerobic microorganisms. CONCLUSION: Urinary microbiota is implicated in prostatic diseases, especially in BPH, PCa and CP. However, given the relative heterogeneity among published studies, this implication suggests better delineation is needed. Further studies are needed to confirm these findings.
引用
- Mjaess G, Karam A, Roumeguère T, et al. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review. Prostate Cancer Prostatic Dis. 2022. PMID: 36209236. doi:10.1038/s41391-022-00602-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。